Vaccine Information: FLUZONE High-Dose Quadrivalent Northern Hemisphere (Page 4 of 4)
PRINCIPAL DISPLAY PANEL — 0.7 mL Syringe Label
NDC 49281-120-88
0.7 mL Single-Dose
Influenza Vaccine
Fluzone® High-Dose
Quadrivalent
2020-2021 Formula
For 65 yrs of age and older
Mfd by: Sanofi Pasteur Inc.
IM only Rx only
PRINCIPAL DISPLAY PANEL — 0.7 mL Syringe Package
NDC 49281-120-65
2020-2021 Formula
For Intramuscular
Injection Only
10 Single-Dose
Prefilled Syringes
0.7 mL each
Rx only
Influenza Vaccine
Fluzone® High-Dose
Quadrivalent
FOR ADULTS 65+
SANOFI PASTEUR
FLUZONE HIGH-DOSE QUADRIVALENT NORTHERN HEMISPHERE influenza a virus a/guangdong-maonan/swl1536/2019 cnic-1909 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/hong kong/2671/2019 (h3n2) antigen (formaldehyde inactivated), influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated), and influenza b virus b/washington/02/2019 antigen (formaldehyde inactivated) injection, suspension | ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
|
Labeler — Sanofi Pasteur Inc. (086723285) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Sanofi Pasteur Inc. | 086723285 | MANUFACTURE (49281-120) |
Revised: 02/2021 Sanofi Pasteur Inc.
VxLabels.com provides trustworthy package insert and label information about marketed drugs and vaccines as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VxLabels.com. Every individual vaccine label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.
https://vxlabels.com/lib/vaccines/vax/fluzone-high-dose-quadrivalent-northern-hemisphere/page/4/